Gregory Barron, MD is a rheumatology internal medicine in Denver, CO with 12 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Gregory Barron, MD NPI is 1871859801. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Graduation Year:2012
The provider's business location address is:
7111 E LOWRY BLVD STE 200
DENVER, CO
ZIP 80230-360
Phone: (303) 394-2828
Fax: (303) 320-0242
The NPI 1871859801 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Infusion of chemotherapy into a vein up to 1 hour (HCPCS:96413)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Injection of different drug or substance into a vein for therapy, diagnosis, or prevention (HCPCS:96375)
- Aspiration and/or injection of large joint or joint capsule (HCPCS:20610)
- Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour (HCPCS:96365)
- Bone density measurement using dedicated x-ray machine (HCPCS:77080)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Vaccine for influenza for injection into muscle (HCPCS:90662)
The enumeration date for this NPI number is 4/4/2012 and was last updated on 9/7/2023.